HLA-DQ alleles associate with cutaneous features of onchocerciasis

Human Immunology

Volumn 55, Issue 1, 1997, Pages 46-52

  Murdoch, Michele E ^a,b,e,i   Payton, Antony ^c   Abiose, Adenike ^a,f   Thomson, Wendy ^c   Panicker, Vinod K ^d,h   Dyer, Philip A ^d   Jones, Barrie R ^a,g   Maizels, Rick M ^b   Oilier, William E R ^c  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f National Eye Centre   (Nigeria)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h SRI RAMACHANDRA UNIVERSITY   (India)

ⁱ WATFORD GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; IVERMECTIN;

ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOPATHOLOGY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; ONCHOCERCA; ONCHOCERCIASIS; PARASITE IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0030930145     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00089-X     Document Type: Article

References (27)

1. World Health Organization: Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. WHO Tech Report Series 852:1, 1995.
2. Mackenzie CD, Williams JF, Sisley BM, Steward MW, O'Day J: Variations in host responses and the pathogenesis of human onchocerciasis. Rev Infect Dis 7:802, 1985.
3. World Health Organization: The importance of onchocercal skin disease. Report of a multicountry study by the Pan-African Study Group on onchocercal skin disease. Geneva, World Health Organization, 1995. TDR/AFR/RP/95.1.
4. Murdoch ME, Hay RJ, Mackenzie CD, Williams JF, Ghalib HW, Cousens S, Abiose A, Jones BR: A clinical classification and grading system of the cutaneous changes in onchocerciasis. Brit J Dermatol 129:260, 1993.
5. Ottesen EA: Immunological aspects of lymphatic filariasis and onchocerciasis in man. Trans R Soc Trop Med Hyg 78:9, 1984.
6. Bundy DAP, Grenfell BT, Rajagoplan PK: Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease. Immunology Today 12:A71, 1991.
7. Brattig NW, Tischendorf FW, Reifegerste S, Albiez EJ, Berger J: Differences in the distribution of HLA antigens in localized and generalized forms of onchocerciasis. Trop Med Parasitol 37:271, 1986.
8. Meyer CG, Gallin M, Erttmann KD, Brattig N, Schnittger L, Gelhaus A, Tannich E, Begovich AB, Erlich HA, Horstmann RD: HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc Natl Acad Sci, USA 91:7515, 1994
9. Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A, Babalola OE, Alexander NDE, Nuhu I, Evans J, Ibrahim UF, Mahmood AO: Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 341:130, 1993.
10. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Isolation of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 21 Suppl 97:77, 1968.
11. Williams E, Okoye R, Ollier W, Festenstein H: A simple box method for freezing lymphocytes (letter). J Immunol Methods 65:265, 1983.
12. Martin S, Dyer PA: Identification and importance of MHC. The definition of HLA specificities by cytotoxicity. Transpl Immunol 2:108, 1994.
13. Saiki RK, Walsh PS, Levenson CH, Erlich HA: Genetic analysis of amplified DNA with immobilised sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 86:6230, 1989.
14. Angelini G, de Preval C, Gorski J, Mach B: High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 83:4489, 1986.
15. Mittal KK, Hasegaca T, Ting H, Mickey MR, Terasaki PI: Variation in the HLA system between Ainus, Japanese and Caucasians: In Dausset J, Colomban J (eds): Histocompatibility Testing. Copenhagen, Munksgaard, 1972.
16. Cavalli-Sforza LL, Bodmer WF: The genetics of human populations. San Francisco, WH Freeman and Co., 1971.
17. Maizels RM, Lawrence RA: Immunological tolerance: the key feature in human filariasis? Parasitology Today 7:271, 1991.
18. Murdoch ME, Abiose A, Garate T, Hay RJ, Jones BR, Maizels RM, Parkhouse RME: Human onchocerciasis in Nigeria: isotypic responses and antigen recognition in individuals with defined cutaneous pathology. Am J Trop Med Hyg 54:600, 1996.
19. Nishimura Y, Kamikawaji N, Fujisawa K, Yoshizumi H, Yasunami M, Kimura A, Sasazuki T: Genetic control of immune response and disease susceptibility by the HLA-DQ gene. Res Immunol 142:459, 1991.
20. Nepom GT, Erlich H: MHC Class-II molecules and autoimmunity. Annu Rev Immunol 9:493, 1991.
21. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T: HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327:426, 1987.
22. + T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 88:2598, 1991.
23. Yazdanbakhsh M, Sartono E, Kruize YCM, Kurniawan A, Partono F, Maizels RM, Schreuder GMT, Schipper R, de Vries RRP: HLA and elephantiasis in lymphatic filariasis. Hum Immunol 44:58, 1995.
24. Max H, Halder T, Kalbus M, Gnau V, Jung G, Kalbacher H: A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4-Dw4-associated self-peptide. Hum Immunol 41:39, 1994.
25. Sontheimer RD, Lieu T-S, Capra JD: Calreticulin: the diverse functional repertoire of a new human autoantigen. Immunologist 1:155, 1993.
26. Okoye RC, Ollier W, Jaraquemada D, Awad J, Navarrete C, Cutbush S, Carthy D, Dos-Santos A, Festenstein H: HLA-D region heterogeneity in a Nigerian population. Tissue Antigens 33:445, 1989.
27. Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC, Thomson W, Pepper L: Absense of rheumatoid arthritis in a rural Nigerian population. J Rheumatol 20:618, 1993.